BATS:AZNH AstraZeneca PLC ADRhedged (AZNH) Price, Holdings, & News $44.80 +44.80 (+∞) As of 01:38 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsRatingsBuy This Stock About AstraZeneca PLC ADRhedged (BATS:AZNH) 30 days 90 days 365 days Advanced Chart Get AZNH alerts:Sign Up Key Stats Today's Range N/A50-Day Range$40.88▼$46.4552-Week Range N/AVolume113 shsAverage Volume5,141 shsMarket CapitalizationN/AAssets Under ManagementN/ADividend Yield6.48%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF Overview The AstraZeneca PLC ADRhedged (AZNH) is an exchange-traded fund that mostly invests in health care equity. The fund provides exposure to AstraZeneca ADR, while using swaps to hedge daily currency fluctuations. The fund aims to provide the total return performance of AstraZeneca Plc, in its local market, to US investors. AZNH was launched on Oct 1, 2024 and is issued by ADRhedged. Read More AstraZeneca PLC ADRhedged ExpensesTypeAZNHSingle Stock ETFsEquity ETFsBATS ETFsAll ETFsManagement Fee0.17%0.93%0.56%0.57%0.53%Other Expenses0.02%0.64%0.56%0.48%0.56%Total Expense0.19%1.35%0.76%0.71%0.73%Fee Waiver0.00%-1.02%-0.66%-0.46%-0.63%Net Expense0.19%1.03%0.63%0.64%0.60% Receive AZNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AstraZeneca PLC ADRhedged and its competitors with MarketBeat's FREE daily newsletter. Email Address AZNH ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com AZNH ETF - Frequently Asked Questions How do I buy shares of AstraZeneca PLC ADRhedged? Shares of AZNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerPrecidian Funds Fund NameAstraZeneca PLC ADRhedged Tax ClassificationRegulated Investment Company Stock ExchangeBATSCurrent SymbolBATS:AZNH Inception Date10/1/2024 Fund ManagerDaniel McCabe, Mark Criscitello WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkAstraZeneca PLC (NASDAQ: AZN) CategoryStrategy FocusSingle Stock Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$0.00 Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorPrecidian Funds, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerCitadel Miscellaneous Outstanding Shares60,001BetaN/A Creation Unit25,000 Creation Fee$250.00 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Top 6 AZNH HoldingsU.S. DollarHolding Weight: 184.98%AstraZeneca (NASDAQ:AZN)Holding Weight: 97.16%Great British PoundHolding Weight: 90.86%Dreyfus Treasury Securities Cash ManagementHolding Weight: 2.58%Great British PoundHolding Weight: -90.86%U.S. DollarHolding Weight: -184.72%Full Holdings Details This page (BATS:AZNH) was last updated on 8/12/2025 by MarketBeat.com Staff From Our Partners#1 Pre-IPO Opportunity For 2025 [Take Action Now!]James Altucher has scored 37X and even 60X returns on past pre-IPO deals. But now he says a much bigger opport...Paradigm Press | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC ADRhedged Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca PLC ADRhedged With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access